Ardelyx (ARDX) Liabilities and Shareholders Equity (2013 - 2026)

Ardelyx (ARDX) reported Liabilities and Shareholders Equity of $504.5 million for Q1 2026, up 22.99% on a YoY basis from $410.2 million in Q1 2025, and up 0.58% quarter-over-quarter from $501.6 million in Q4 2025.

Ardelyx (ARDX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Ardelyx has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $504.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 22.99% year-over-year to $504.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (up 25.8% YoY), and the FY2025 full-year result was $501.6 million, up 15.11% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $504.5 million, up from $501.6 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $504.5 million in Q1 2026, with the low at $129.4 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $321.7 million across 5 years, with a median of $342.4 million in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity tumbled 38.46% — and 2023, when it soared 100.02%.
  • Ardelyx's Liabilities and Shareholders Equity stood at $190.1 million in 2022, then soared by 56.57% to $297.6 million in 2023, then soared by 46.43% to $435.8 million in 2024, then advanced by 15.11% to $501.6 million in 2025, then increased by 0.58% to $504.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $504.5 million (Q1 2026), $501.6 million (Q4 2025), and $486.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 504.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 504.51 Mn
Dec 31, 2025 501.60 Mn
Sep 30, 2025 486.17 Mn
Jun 30, 2025 466.77 Mn
Mar 31, 2025 410.19 Mn
Dec 31, 2024 435.75 Mn
Sep 30, 2024 367.86 Mn
Jun 30, 2024 343.49 Mn
Mar 31, 2024 342.38 Mn
Dec 31, 2023 297.58 Mn
Sep 30, 2023 289.38 Mn
Jun 30, 2023 211.20 Mn
Mar 31, 2023 217.02 Mn
Dec 31, 2022 190.07 Mn
Sep 30, 2022 144.67 Mn
Jun 30, 2022 131.61 Mn
Mar 31, 2022 129.41 Mn
Dec 31, 2021 149.91 Mn
Sep 30, 2021 170.85 Mn
Jun 30, 2021 204.98 Mn